1800 202 8726
Understanding your biopsy report

What a Biopsy Tells You — Beyond Yes or No

Most people expect a biopsy result to come back as simply positive or negative. It tells your oncologist far more than that — the type of cancer, how the cells behave, and which specific treatments are likely to apply to you.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Not just a yes or no — Your biopsy report contains several separate pieces of information, each of which shapes a different part of your treatment plan.
  • Type, grade, and markers — These three things together determine which treatment family applies to your cancer and how urgently it needs to start.
  • One sample, many tests — The same piece of tissue is processed in multiple ways, which is why the full report arrives in stages rather than all at once.
  • The report opens decisions — A biopsy result does not close the conversation — it answers the questions that your treatment plan is built on.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A biopsy does more than say whether cancer is present. The tissue your pathologist examines tells your oncologist what type of cancer it is, how the cells are behaving, and which specific markers are present. Those three things together are what your treatment plan is built on.

What do the terms in a biopsy report mean?

Cancer type (histology)
Which kind of cell the cancer started from. Carcinoma means it began in lining or glandular cells, sarcoma in connective tissue, lymphoma in immune cells. This is the most fundamental piece of information in the report — it tells your oncologist which treatment family to consider.
Grade
How different the cancer cells look compared to normal cells under a microscope. Low grade means the cells look almost normal and tend to grow less quickly. High grade means the cells look very abnormal. Grade influences how urgently treatment should begin and what intensity is needed.
Receptor and marker status
Whether the cancer cells carry specific proteins on their surface. In breast cancer, oestrogen receptor status decides whether hormone therapy applies. In lung cancer, EGFR or ALK status decides whether a targeted drug is an option. Each cancer type has its own relevant markers.
Ki-67
A measure of how quickly the cells are dividing, reported as a percentage. Your oncologist uses it alongside grade to understand how active the cancer is. It is one piece of a larger picture, not a standalone decision-maker.
Margins
Relevant when a surgical biopsy or excision is done. A clear margin means no cancer cells were seen at the cut edge of the removed tissue. A positive or close margin may mean more surgery or additional treatment is needed.
Lymphovascular invasion
Whether cancer cells have been found in the small blood or lymph vessels near the tumour. If present, it indicates a possibility that cells may have begun to travel — even if no spread has been confirmed on imaging yet.

What does a biopsy tell you that a scan cannot?

QuestionBiopsyImaging scan (CT / MRI / PET)
Is cancer confirmed?Yes — from examining actual cellsCannot confirm — identifies a suspicious area
Which cell type?YesNo
Grade and cell behaviourYesNo
Spread to lymph nodes or organsNoYes
Tumour size and precise locationApproximate onlyDetailed
Receptor and biomarker statusYesNo

What does each part of the report decide about your treatment?

The cancer type tells your oncologist which treatment family applies — chemotherapy, targeted therapy, hormone therapy, immunotherapy, or a combination.

Grade and Ki-67 together influence how urgently treatment should begin and how intensive it needs to be.

Receptor and biomarker results decide whether specific drugs are likely to work. A drug that works only for HER2-positive breast cancer will not help someone whose tumour does not carry that marker.

This is why your oncologist waits for the full report before recommending a plan. Each part of it answers a different question about your treatment.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What should a full biopsy report tell you before treatment starts?

  • The cancer type and the specific cell it started from
  • The grade, and what that means for how this cancer tends to behave
  • Whether receptor or marker testing was done, and what it showed
  • Whether margins are clear, if a surgical biopsy or excision was performed
  • Whether molecular or biomarker testing has been ordered or is still pending
  • When the complete report — including any pending tests — will be ready

Why does one small sample take time — and answer so much?

The tissue from your biopsy is not examined just once. Your pathologist first sections and stains it to see the shape and arrangement of cells — this gives the cancer type and grade.

The same tissue block is then used for immunohistochemistry, which detects specific proteins on the cell surface and gives the receptor and marker results.

If molecular testing is needed — for genes such as EGFR, KRAS, BRCA, or others relevant to your cancer — it also runs on the same sample.

This is why the full report arrives in stages. Each layer of testing takes additional time, but it uses the tissue you have already provided.

Questions families ask about biopsy reports

What if the report says the result is inconclusive?

An inconclusive result means the pathologist could not reach a clear answer from the sample — either because the sample was too small, not from the right area of the lesion, or because the cells sit in a genuinely uncertain category. Your oncologist will explain whether a repeat biopsy is needed, whether the sample can be reviewed at a specialist centre, or whether other tests can help. An inconclusive result is not a diagnosis, and it is not a clearance either. It means more information is needed before any decision is made.

What does a high grade actually mean for me?

A high grade tells your oncologist that the cancer cells look very different from normal and tend to behave more aggressively. This usually influences how urgently treatment begins and which approach is recommended. It does not by itself tell you what the outcome will be — grade sits alongside cancer type, stage, and marker results as one piece of information. Your oncologist can explain what grade means specifically for your type of cancer, because its significance varies between cancer types.

Can the grade found at biopsy differ from what surgery shows?

Yes, it can. A biopsy samples a small part of the tumour, and some tumours are not uniform throughout — one area may look different from another. The pathologist examining the full surgical specimen has access to the whole tumour and may reach a slightly different conclusion. This is not an error; it reflects the limits of sampling one small area. Your oncologist will use the most complete information available at each decision point, and any difference between biopsy and surgical findings will be explained to you.

What if not all the markers relevant to my cancer were tested?

It is worth asking your oncologist directly whether all markers relevant to your cancer type were included in the report, and whether any results are still pending. Some markers are tested routinely on all cases of a cancer type; others are only ordered when the initial result suggests they are relevant. If a specific treatment is being recommended, ask which marker result that recommendation is based on. Testing can sometimes be added later if the original tissue block still has sufficient material.

Will I need another biopsy?

Most treatment decisions are made from the original biopsy. A second biopsy may be needed if the first sample was inconclusive, if the cancer changes during treatment and a new decision point arises, or if a new site of disease appears and needs to be assessed. Some cancers also have liquid biopsy options — a blood test that detects tumour DNA — which may reduce the need for repeat tissue sampling in certain situations. Your oncologist will tell you if another procedure is needed and explain the reason for it.

How long should I wait before asking for the full report?

Standard histology with common marker tests typically takes one to two weeks, though this varies by laboratory and by which tests are ordered. Molecular or genetic tests can take longer. If a date was given and has passed without news, following up is reasonable — not impatient. Ask whether all parts of the report are back or whether something is still pending, and when you can expect a discussion of the complete results. Waiting without a timeline is harder than waiting with one.

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is a biopsy result the same as a diagnosis?

A biopsy provides the information your pathologist and oncologist use to reach a diagnosis, but it is also the starting point for understanding what kind of cancer it is, how it behaves, and which treatments are likely to help. Some reports come back in stages — a preliminary finding followed by more detailed marker results. Your oncologist will explain what each part means once the relevant tests are complete, rather than drawing conclusions from a partial picture.

How do I read my biopsy report if I have a copy?

Biopsy reports are written for pathologists and oncologists, so the language can be difficult to interpret on your own. The parts that connect most directly to your treatment are the cancer type, the grade, and the receptor or marker results. If a word or finding worries you, write it down and bring it to your appointment rather than searching for it online without context. Your oncologist is the right person to explain what each finding means for your specific situation.

What is immunohistochemistry and why does it add time to the report?

Immunohistochemistry (IHC) runs on the same tissue block as the standard staining but is a separate process, which is why it adds time to the full report. It uses antibodies to detect specific proteins on the surface of cancer cells — markers such as HER2, ER, PR, or PD-L1 depending on your cancer type. These results often decide whether a targeted drug or immunotherapy applies to you. The extra time is a sign that thorough testing is being done, not that something has gone wrong.

What is a liquid biopsy and is it the same as a tissue biopsy?

A liquid biopsy is a blood test that detects fragments of tumour DNA circulating in the bloodstream. It is not a replacement for a tissue biopsy — examining tissue remains the standard for determining cancer type, grade, and most marker results. Liquid biopsy is used in specific situations: monitoring response to treatment, detecting early signs of recurrence, or checking for new mutations when a repeat tissue procedure is not practical. Your oncologist will advise whether it applies to your situation.

Should I get a second opinion on my biopsy report?

Seeking a second pathology opinion is a recognised part of cancer care, and a responsible oncologist will not discourage it. It is most useful when the diagnosis is rare, the grade is borderline, or the initial report is inconclusive. If you want one, ask your oncologist to arrange for the original slides or tissue block to be sent to a specialist pathology centre. A second opinion on the report is separate from a second clinical opinion on the treatment plan — both are reasonable to request.

Does the biopsy report tell you the stage of cancer?

No. Stage is determined by combining biopsy findings with imaging — CT, MRI, PET-CT, or bone scans — that show whether the cancer has spread to lymph nodes or other parts of the body. The biopsy tells you what the cancer is; imaging tells you where it is and how far it has extended. Both are needed before staging is complete, and your oncologist will usually discuss stage with you after both sets of results are available.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation